Cinacalcet medication adherence at the time of alteration of ethelcalcitide from cinacalcet

Cinacalcet medication adherence at the time of alteration of ethelcalcitide from cinacalcet - Cinacalcet medication adherence at the time of alteration of ethelcalcitide from cinacalcet

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034645

Enrollment

Registered

2018-10-25

Start date

2018-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients with secondary hyperparathyroidism

Exclusion criteria

Exclusion criteria: Patients complicated with serious diseases such as cancer, hematological disorders, and liver cirrhosis

Design outcomes

Primary

Measure	Time frame
Difference in good cinacalcet medication adherence group and poor group divided by serum iPTH increase rate before and after cinacalcet withdrawal	—

Countries

Japan

Contacts

Public ContactMichio Kuwahara

Saitama Tsukinomori Clinic Nephrology

kuwahara@k-naika-cl.jp048-792-1811

Outcome results